Mumps
📧 Sign up to get email alerts when something new happens for Mumps.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-02-09Clinical Trial Update: Safety, Tolerability, and Immunogenicity of 3 Frozen ProQuad Consistency Lots in Healthy Children (V221-012)(COMPLETED) [Phase 3]
This Phase 3 clinical trial evaluated safety, tolerability, and immunogenicity across three frozen ProQuad lot consistency lots in healthy c…
-
CLINICAL_TRIALS trial_result · 2010-01-29Clinical Trial Update: A Study of ProQuad in Healthy 4 to 6 Year Old Children (V221-014) [Phase 3]
Phase 3 trial of ProQuad in healthy children completed; results posted in 2010.
-
CLINICAL_TRIALS trial_result · 2009-07-03Clinical Trial Update: Seroimmunity 2007 and Sub Study of the Swedish Population Regarding Vaccine Preventable Disease
Clinical trial update on Seroimmunity 2007 and a sub-study of the Swedish population assessing seroprevalence for vaccine-preventable diseas…
-
CLINICAL_TRIALS trial_result · 2008-11-20Clinical Trial Update: Hepatitis A Vaccine, Inactivated and Measles, Mumps, Rubella and Varicella Virus Vaccine Live Safety Study (V251-066)(COMPLETED) [Phase 4]
A Phase 4 safety study evaluating Merck's Hepatitis A inactivated vaccine and Measles, Mumps, Rubella and Varicella Live vaccine (ProQuad) h…
-
CLINICAL_TRIALS trial_result · 2008-10-13Clinical Trial Update: Immunogenicity/Safety of Measles-Mumps-Rubella-Varicella Vaccine (MeMuRu-OKA): Using Two Different Administration Routes [Phase 3]
Phase 3 trial evaluating immunogenicity and safety of Measles-Mumps-Rubella-Varicella Vaccine (MeMuRu-OKA) using two administration routes; …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2008-03-28Clinical Trial Update: The Influence of Probiotics on the Immunologic Response to Vaccinations in Infants [NA]
Clinical trial exploring whether probiotics modulate infants' immunologic response to vaccines, with a focus on measles, mumps, and rubella;…
-
CLINICAL_TRIALS trial_result · 2008-02-08Clinical Trial Update: Trial to Assess Safety, Tolerability, and Immunogenicity of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold-Adapted (FluMist) and Measles, Mumps, Rubella, and Varicella Vaccines Administered Concurrently to Healthy Children [Phase 3]
A Phase 3 trial evaluated safety, tolerability, and immunogenicity when FluMist and MMRV vaccines were administered concurrently to healthy …